Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beers

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Immunity|November 18, 2018
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector FunctionSarah L Buchan, Lang Dou, Marcus Remer, et al.
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 8, 2022
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapyKhiyam Hussain, Rena Liu, Rosanna C G Smith, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Immunity|November 18, 2018
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector FunctionSarah L Buchan, Lang Dou, Marcus Remer, et al.
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 8, 2022
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapyKhiyam Hussain, Rena Liu, Rosanna C G Smith, et al.
Pageof 11